No more subsidised Truvada for Australians, but there are alternatives

starobserver.com.au:

Australians will no longer be able to access Truvada, used for HIV treatment as well as for pre-exposure prophylaxis (PrEP), through the Pharmaceutical Benefits Scheme (PBS).

Truvada was delisted from the subsidy scheme from April 1, 2020. The Australian Federation of AIDS Organisations said that there were alternatives to Truvada for PrEP in Australia. PrEP taken as a pill once daily is known to reduce HIV transmission by 99 percent.

For many persons who use Truvada for PrEP, this couldn’t have come at a worse time, in the midst of the global outbreak of the novel Coronavirus. “I was contacted by my pharmacy and advised that my monthly cost for a Truvada will now be $41 as of Wednesday April 1,” Max Burns (name changed to protect